Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
作者信息
Ruggiero Angelo, Marasca Claudio, Fabbrocini Gabriella, Villani Alessia, Martora Fabrizio
机构信息
Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
出版信息
J Cosmet Dermatol. 2023 Feb;22(2):677-678. doi: 10.1111/jocd.15292. Epub 2022 Aug 31.
Abstract
摘要
相似文献
1
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?化脓性汗腺炎管理中的远程皮肤病学：我们是否应该改善这项服务？
J Cosmet Dermatol. 2023 Feb;22(2):677-678. doi: 10.1111/jocd.15292. Epub 2022 Aug 31.
2
Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?化脓性汗腺炎合并多发性脂囊瘤：是化脓性汗腺炎的一种新变异型吗？
J Cutan Med Surg. 2021 Nov-Dec;25(6):586-590. doi: 10.1177/12034754211010145. Epub 2021 Apr 28.
3
[Letter to the Editor - "Guidelines for Management of Patients with Hidradenitis Suppurativa": The Importance of Collaboration with Infectious Diseases].[致编辑的信——“化脓性汗腺炎患者的管理指南”：与传染病学科协作的重要性]
Acta Med Port. 2024 Mar 1;37(3):231-232. doi: 10.20344/amp.20788.
4
Hidradenitis suppurativa.化脓性汗腺炎
J Cutan Med Surg. 2003 Jan-Feb;7(1):47-56. doi: 10.1007/s10227-002-2104-z. Epub 2002 Dec 4.
5
Hidradenitis suppurativa: Demystifying a chronic and debilitating disease.化脓性汗腺炎：揭开一种慢性致残性疾病的神秘面纱。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S1-2. doi: 10.1016/j.jaad.2015.08.061.
6
[Update of hidradenitis suppurativa in Primary Care].[基层医疗中化脓性汗腺炎的更新内容]
Semergen. 2017 Jan-Feb;43(1):34-42. doi: 10.1016/j.semerg.2015.12.005. Epub 2016 Feb 11.
7
[Management of hidradenitis suppurativa].[化脓性汗腺炎的管理]
Rev Prat. 2024 May;74(5):471-476.
8
Hidradenitis suppurativa.化脓性汗腺炎
JAAPA. 2019 Jan;32(1):47-48. doi: 10.1097/01.JAA.0000550296.68348.31.
9
Hidradenitis Suppurativa in the Military.化脓性汗腺炎在军队中的情况。
Cutis. 2020 Oct;106(4):181-184. doi: 10.12788/cutis.0095.
10
Multidisciplinary approach for hidradenitis suppurativa patients.化脓性汗腺炎患者的多学科治疗方法。
G Ital Dermatol Venereol. 2018 Jun;153(3 Suppl 2):18-19. doi: 10.23736/S0392-0488.17.05779-0.
引用本文的文献
1
The use of teledermatology and eHealth apps in hidradenitis suppurativa: a scoping review.化脓性汗腺炎中远程皮肤病学和电子健康应用程序的使用：一项范围综述
Arch Dermatol Res. 2025 Jan 15;317(1):247. doi: 10.1007/s00403-024-03732-4.
2
Dermatologists' Perceptions of the Use of Teledermatology in Managing Hidradenitis Suppurativa: Survey Study.皮肤科医生对使用远程皮肤病学管理化脓性汗腺炎的看法：调查研究
JMIR Dermatol. 2023 Jan 31;6:e43910. doi: 10.2196/43910.
3
The Impact of Telemedicine on Patients with Hidradenitis Suppurativa in the COVID-19 Era.远程医疗对 COVID-19 时代化脓性汗腺炎患者的影响
Healthcare (Basel). 2023 May 17;11(10):1453. doi: 10.3390/healthcare11101453.
4
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?常见炎症性皮肤病的远程皮肤病学：未来医学？
Life (Basel). 2023 Apr 18;13(4):1037. doi: 10.3390/life13041037.
5
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.远程皮肤病学在2019年冠状病毒病大流行期间的作用：一项叙述性综述
Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793. doi: 10.2147/CCID.S377029. eCollection 2022.
本文引用的文献
1
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department'.COVID-19大流行期间患者对远程皮肤科会诊的满意度。评《对英国首波COVID-19大流行期间在单一二级护理皮肤科部门使用的远程皮肤科会诊患者满意度的定性评估》
Clin Exp Dermatol. 2022 Nov;47(11):2037-2038. doi: 10.1111/ced.15326. Epub 2022 Aug 12.
2
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns.COVID-19期间视频与电话远程皮肤病学会诊的比较：患者满意度、疑问与担忧
Clin Exp Dermatol. 2022 Oct;47(10):1863-1864. doi: 10.1111/ced.15286. Epub 2022 Jul 12.
3
Teledermatology in the time of COVID-19.新冠疫情时期的远程皮肤病学。
Int J Clin Pract. 2021 Dec;75(12):e15000. doi: 10.1111/ijcp.15000. Epub 2021 Nov 4.
4
Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.老年银屑病患者的抗白细胞介素-23 治疗：真实世界中 Guselkumab、Risankizumab 和 Tildrakizumab 的应用。
Clin Exp Dermatol. 2022 Mar;47(3):561-567. doi: 10.1111/ced.14979. Epub 2021 Nov 17.
5
May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?新冠疫情爆发是否会导致皮肤慢性炎症性疾病恶化？
Med Hypotheses. 2020 Oct;143:109853. doi: 10.1016/j.mehy.2020.109853. Epub 2020 May 19.
6
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy.新冠疫情时代针对化脓性汗腺炎患者的生物制剂：来自意大利南部一家转诊中心的数据。
J Dermatolog Treat. 2022 Feb;33(1):592. doi: 10.1080/09546634.2020.1769828. Epub 2020 May 25.
Zotero 插件